Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1621-1630 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|September 15, 2018
EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodiesHeather A Cooke, Joe Arndt, Chao Quan, et al.
Mabs|January 23, 2010
Antibody fragments: hope and hypeAaron L Nelson
Mabs|January 19, 2010
Evolution of anti-CD20 monoclonal antibody therapeutics in oncologyEzogelin Oflazoglu, Laurent P Audoly
Mabs|June 15, 2019
Engineering an anti-CD52 antibody for enhanced deamidation stabilityHuawei Qiu, Ronnie Wei, Julie Jaworski, et al.
Mabs|August 28, 2018
Discovery, characterization, and remediation of a C-terminal Fc-extension in proteins expressed in CHO cellsChristopher S Spahr, Mark E Daris, Kevin C Graham, et al.
Mabs|June 27, 2019
Influence of the bispecific antibody IgG subclass on T cell redirectionStephanie Kapelski, Erna Cleiren, Ricardo M Attar, et al.
Mabs|June 22, 2019
Native peptide mapping - A simple method to routinely monitor higher order structure changes and relation to functional activityMichel Degueldre, Annemie Wielant, Eglantine Girot, et al.
Mabs|April 6, 2018
Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in miceWolfgang F Richter, Gregory J Christianson, Nicolas Frances, et al.
Mabs|June 29, 2017
Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's diseaseMatthias Vandesquille, Tengfei Li, Chrystelle Po, et al.
Mabs|March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myelomaMarije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.
Pageof 178

Showing results (1621-1630 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|September 15, 2018
EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodiesHeather A Cooke, Joe Arndt, Chao Quan, et al.
Mabs|January 23, 2010
Antibody fragments: hope and hypeAaron L Nelson
Mabs|January 19, 2010
Evolution of anti-CD20 monoclonal antibody therapeutics in oncologyEzogelin Oflazoglu, Laurent P Audoly
Mabs|June 15, 2019
Engineering an anti-CD52 antibody for enhanced deamidation stabilityHuawei Qiu, Ronnie Wei, Julie Jaworski, et al.
Mabs|August 28, 2018
Discovery, characterization, and remediation of a C-terminal Fc-extension in proteins expressed in CHO cellsChristopher S Spahr, Mark E Daris, Kevin C Graham, et al.
Mabs|June 27, 2019
Influence of the bispecific antibody IgG subclass on T cell redirectionStephanie Kapelski, Erna Cleiren, Ricardo M Attar, et al.
Mabs|June 22, 2019
Native peptide mapping - A simple method to routinely monitor higher order structure changes and relation to functional activityMichel Degueldre, Annemie Wielant, Eglantine Girot, et al.
Mabs|April 6, 2018
Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in miceWolfgang F Richter, Gregory J Christianson, Nicolas Frances, et al.
Mabs|June 29, 2017
Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's diseaseMatthias Vandesquille, Tengfei Li, Chrystelle Po, et al.
Mabs|March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myelomaMarije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.
Pageof 178